ACTRN12617001209381
Completed
未知
Evaluation of the efficacy of Group Triple P – Positive Parenting Program to enhance co-parenting practice between parent and grandparent in Vietnam: Randomized Controlled Trial
April Hoang0 sites120 target enrollmentAugust 18, 2017
ConditionsIntergenerational conflict in parenting
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Intergenerational conflict in parenting
- Sponsor
- April Hoang
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effectiveness of the Triple P programme to support parenting in Dutch Preventive Child healthcare: a randomised controlled studychildhood emotional & behavioural problemspsychosocial problems10001474NL-OMON31309niversitair Medisch Centrum Groningen162
Not yet recruiting
Phase 2
Evaluation and comparison of the efficacy of triple therapies regimens containing esomeprazole and different doses of amoxicillin and bismuth for eradicating Helicobacter pylori infection in SariIRCT20210518051335N1Mazandaran University of Medical Sciences200
Not yet recruiting
Phase 2
Comparison of effectiveness of Triphala Ghritapana and Viddhakarma with Antioxidants Therapy in Vataja Timira (Age Related Macular Degeneration Dry type )Health Condition 1: H353- Degeneration of macula and posterior poleCTRI/2023/04/051277Dr Vaishnavi Yashwant Jugdhar
Completed
Not Applicable
The interventional effect of Triple P; positive parenting program regarding mothers of children with cleft lip and/or palateCleft Lip and/or PalateJPRN-UMIN000023053Osaka University Dental Hospital10
Active, not recruiting
Not Applicable
ASSESSMENT OF THE EFFICACY AND SAFETY OF THREE CONCENTRATIONS: 1%, 0.3%, 0.1% OF CD5024 CREAM ONCE DAILY AND CD5024 1% CREAM TWICE DAILY, VERSUS ITS VEHICLE AND VERSUS METRONIDAZOLE 0.75% CREAM (ROZEX®), IN PATIENTS WITH PAPULO-PUSTULAR ROSACEA OVER 12 WEEKSPatients with papulo-pustular rosaceaMedDRA version: 9.0Level: LLTClassification code 10039218EUCTR2006-001999-20-CZGalderma Research & Development SNC270